Evidence map›Paper›PMID 24940603›Full record

ArticlePloS one2014

New Clox Systems for rapid and efficient gene disruption in Candida albicans.

Shahida Shahana, Delma S Childers, Elizabeth R Ballou, Iryna Bohovych, Frank C Odds, Neil A R Gow, Alistair J P Brown

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Antimicrobial agents and chemotherapy · 2025
    Article
  4. The role of themSphere · 2024
    Article
  5. Article
  6. Evaluation of a NovelJournal of fungi (Basel, Switzerland) · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Nine Things Genomics Can Tell Us AboutFrontiers in genetics · 2020
    Review
  12. Article
  13. Article
  14. Article
  15. Structural andmBio · 2017
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shahida ShahanaSchool of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.
Delma S ChildersSchool of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.
Elizabeth R BallouSchool of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.
Iryna BohovychSchool of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.
Frank C OddsSchool of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.
Neil A R GowSchool of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.
Alistair J P BrownSchool of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.
University of Aberdeen · GB

Funding

Biotechnology and Biological Sciences Research Council BB/F00513X/1Wellcome Trust 080088Wellcome Trust 097377Wellcome Trust 101873
6 · The paper itself

Abstract

Precise genome modification is essential for the molecular dissection of Candida albicans, and is yielding invaluable information about the roles of specific gene functions in this major fungal pathogen of humans. C. albicans is naturally diploid, unable to undergo meiosis, and utilizes a non-canonical genetic code. Hence, specialized tools have had to be developed for gene disruption in C. albicans that permit the deletion of both target alleles, and in some cases, the recycling of the Candida-specific selectable markers. Previously, we developed a tool based on the Cre recombinase, which recycles markers in C. albicans with 90-100% efficiency via site-specific recombination between loxP sites. Ironically, the utility of this system was hampered by the extreme efficiency of Cre, which prevented the construction in Escherichia coli of stable disruption cassettes carrying a methionine-regulatable CaMET3p-cre gene flanked by loxP sites. Therefore, we have significantly enhanced this system by engineering new Clox cassettes that carry a synthetic, intron-containing cre gene. The Clox kit facilitates efficient transformation and marker recycling, thereby simplifying and accelerating the process of gene disruption in C. albicans. Indeed, homozygous mutants can be generated and their markers resolved within two weeks. The Clox kit facilitates strategies involving single marker recycling or multi-marker gene disruption. Furthermore, it includes the dominant NAT1 marker, as well as URA3, HIS1 and ARG4 cassettes, thereby permitting the manipulation of clinical isolates as well as genetically marked strains of C. albicans. The accelerated gene disruption strategies afforded by this new Clox system are likely to have a profound impact on the speed with which C. albicans pathobiology can be dissected.

Indexed as

Gene DeletionGenes, FungalAmino Acid SequenceCandida albicansFungal ProteinsGenetic EngineeringGenetic MarkersHomozygoteIntegrasesIntronsMolecular Sequence DataRecombination, GeneticCre recombinaseFungal ProteinsGenetic MarkersIntegrases

Identifiers

PMID24940603
PMCPMC4062495
OpenAlexW1992605896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.